Advanced search×

Amino acid composition in parenteral nutrition: what is the evidence?

Shadi S Yarandi, Vivian M Zhao, Gautam Hebbar, and Thomas R Ziegler

Curr Opin Clin Nutr Metab Care 14(1):75-82 (2011) PMID 21076291

Complete parenteral nutrition solutions contain mixed amino acid products providing all nine essential amino acids and a varying composition of nonessential amino acids. Relatively little rigorous comparative efficacy research on altered parenteral nutrition amino acid composition has been published in recent years.

DOI: 10.1097/MCO.0b013e328341235a
Version: za2963e q8zab q8zb5 q8zc4 q8zd9 q8ze9 q8zf4 q8zg7
View PDF

Similar articles you may find interesting…

  1. Identification of the nature of reading frame transitions observed in prokaryotic genomes.
    Ivan Antonov, Arthur Coakley, and Mark Borodovsky

    Nucleic Acids Res (2013) PMID 23649834

    We used the ab initio frameshift prediction program, GeneTack, to detect reading frame transitions in 206 991 genes (fs-genes) from 1106 complete prokaryotic genomes. We grouped 102 731 fs-genes into 19 430 clusters based on sequence similarity between protein products (fs-proteins) as well as conse...
    PDF not found
  2. Evaluation of the effect of omega-3 fatty acids in the treatment of premenstrual syndrome: "A pilot trial".
    Nahid Sohrabi, Maryam Kashanian, and Seyed Kazem Malakouti

    Complement Ther Med 21(3):141-6 (2013) PMID 23642943

    Premenstrual syndrome (PMS) refers to a cyclic appearance of somatic and psychiatric symptoms that affect some women. Finding an effective and safe method for the treatment of PMS has always been a serious concern, because approximately 40% of women report PMS, and in 2-10% of cases...
    Buy PDF
  3. C → N and N → C solution phase peptide synthesis using the N-acyl 4-nitrobenzenesulfonamide as protection of the carboxylic function.
    Rosaria De Marco, Mariagiovanna Spinella, and Angelo Liguori

    Org Biomol Chem (2013) PMID 23649304

    We describe a solution phase peptide synthesis strategy using the 4-nitrobenzenesulfonamido/N-methyl-4-nitrobenzenesulfonamido group as a protecting/activating system of the carboxyl function. The 4-nitrobenzenesulfonamido group is stable during peptide chain elongation (Fmoc chemistry). The N-amino...
    Buy PDF